Loria Y - Search Results

1

Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.

Allain H, Le Coz F, Goulley F, Brunet-Bourgin F, Loria Y, Bentue-Ferrer D, Decombe R, Reymann JM, Chaumet-Riffaud P, Gandon JM. Allain H, et al. Among authors: loria y. Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):314-22. Int J Clin Pharmacol Ther Toxicol. 1991. PMID: 1743806 Clinical Trial.

2

Reliability of clinical criteria for the diagnosis of dementia. A longitudinal multicenter study.

Forette F, Henry JF, Orgogozo JM, Dartigues JF, Péré JJ, Hugonot L, Israel L, Loria Y, Goulley F, Lallemand A, et al. Forette F, et al. Among authors: loria y. Arch Neurol. 1989 Jun;46(6):646-8. doi: 10.1001/archneur.1989.00520420066024. Arch Neurol. 1989. PMID: 2658924 Clinical Trial.

3

Electrophysiologic effects of intravenous nicardipine on sinus node function and conduction in humans.

David D, Guize L, Leheuzey JY, Lavergne T, Loria Y, Ourbak P. David D, et al. Among authors: loria y. J Cardiovasc Pharmacol. 1990 Jan;15(1):130-7. doi: 10.1097/00005344-199001000-00021. J Cardiovasc Pharmacol. 1990. PMID: 1688970 Clinical Trial.

4

[Clinical rating scale and psychometric tests in geriatrics--correlation research (author's transl)].

Israel L, Georges D, Lallemand A, Loria Y. Israel L, et al. Among authors: loria y. Therapie. 1979 Sep-Oct;34(5):585-90. Therapie. 1979. PMID: 547438 French. No abstract available.

5

[Treatment of arterial hypertension with a new calcium antagonist: nicardipine].

Bellet M, Loria Y, Lallemand A. Bellet M, et al. Among authors: loria y. Cardiologia. 1987 May;32(5):485-9. Cardiologia. 1987. PMID: 3304631 Clinical Trial. Italian. No abstract available.

6

[Validation by factor analysis of clinical evaluation scale of disorders of cerebral senescence. Use in a therapeutic trial].

Georges D, Lallemand A, Coustenoble J, Loria Y. Georges D, et al. Among authors: loria y. Therapie. 1977 Mar-Apr;32(2):173-80. Therapie. 1977. PMID: 898125 French. No abstract available.

7

First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine.

Bellet M, Loria Y, Lallemand A. Bellet M, et al. Among authors: loria y. J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1149-53. doi: 10.1097/00005344-198511000-00021. J Cardiovasc Pharmacol. 1985. PMID: 2418302 Clinical Trial.

8

Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery.

David D, Dubois C, Loria Y. David D, et al. Among authors: loria y. J Cardiothorac Vasc Anesth. 1991 Aug;5(4):357-61. doi: 10.1016/1053-0770(91)90159-q. J Cardiothorac Vasc Anesth. 1991. PMID: 1873513 Clinical Trial.

9

Isradipine for the treatment of hypertension following coronary artery bypass graft surgery: a randomized trial versus sodium nitroprusside.

Ruegg PC, David D, Loria Y. Ruegg PC, et al. Among authors: loria y. Eur J Anaesthesiol. 1992 Jul;9(4):293-305. Eur J Anaesthesiol. 1992. PMID: 1385778 Clinical Trial.

10

Antihypertensive effects and plasma levels of guanfacine in man.

Safar ME, Loria Y, Weiss YA, Boutier JR Jr. Safar ME, et al. Among authors: loria y. J Clin Pharmacol. 1982 Aug-Sep;22(8-9):385-90. doi: 10.1002/j.1552-4604.1982.tb02690.x. J Clin Pharmacol. 1982. PMID: 6752213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters